[Lupus nephritis and associated thrombotic microangiopathy]

Area of Science:

• Nephrology
• Immunology
• Rheumatology

Background:

• Lupus nephritis is a common lupus complication, increasing chronic kidney disease risk.
• Co-occurrence of lupus nephritis and thrombotic microangiopathy is rare.
• This combination can lead to severe, potentially fatal, organ dysfunction.

Purpose of the Study:

• To report on three rare cases of concurrent lupus nephritis and thrombotic microangiopathy.
• To highlight the challenges in managing these parallel conditions.
• To emphasize the role of intensive immunosuppressive therapy.

Main Methods:

• Case series reporting on three patients.
• Review of clinical data and treatment outcomes.
• Focus on immunosuppressive therapy, including complement blockade.

Main Results:

• Three patients presented with simultaneous lupus nephritis and thrombotic microangiopathy.
• All patients required intensive immunosuppressive treatment.
• Complement blockade was a key component of therapy.

Conclusions:

• Concurrent lupus nephritis and thrombotic microangiopathy is a critical condition.
• Intensive immunosuppressive therapy, particularly with complement blockade, is essential.
• Further research is needed to optimize management strategies for this rare presentation.